Drug intelligence / Profile preview

Venodol

Development stage: Unknown
Lead developer: Spotlight Innovation
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Venodol is an over-the-counter, homeopathic topical analgesic roll-on product formulated with cobra venom as its active ingredient to provide long-lasting relief of chronic pain associated with inflammation, including joint pain, tendinitis, and inflammatory arthritis. It is marketed as a non-addictive, non-narcotic alternative for localized musculoskeletal pain, leveraging the analgesic properties of dilute cobra venom within a homeopathic framework, and is positioned primarily for self-care use in chronic inflammatory pain conditions.

Brand names: Venodol
Other names: Venodol roll-on

Beyond the preview

Go deeper on Venodol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venodol.

Explore the full profile